EyeGate Pharmaceuticals, Inc.
(NASDAQ : EYEG)

( )
EYEG PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
AMRNAmarin Corporation Plc Sponsored ADR
1.53%16.612.0%$163.34m
PRGOPerrigo Co. Plc
-1.50%44.526.8%$125.64m
SAGESAGE Therapeutics, Inc.
2.77%135.609.5%$118.42m
JAZZJazz Pharmaceuticals Plc
0.13%128.172.2%$94.28m
GWPHGW Pharmaceuticals PLC Sponsored ADR
0.05%128.616.3%$74.28m
PTLAPortola Pharmaceuticals, Inc.
2.37%25.537.7%$61.81m
ICPTIntercept Pharmaceuticals, Inc.
-1.13%110.8018.6%$54.35m
MNKMallinckrodt Plc
0.30%20.0121.1%$45.03m
CTLTCatalent Inc
1.67%34.642.4%$41.21m
AXSMAxsome Therapeutics, Inc.
1.51%8.062.7%$40.50m
UTHRUnited Therapeutics Corporation
-1.16%113.6214.4%$39.59m
ICLRICON Plc
-1.85%133.804.1%$39.58m
ENDPEndo International Plc
0.31%9.668.9%$36.88m
HZNPHorizon Pharma plc
-1.04%21.927.4%$30.81m
MDCOMedicines Company
-0.20%19.8021.8%$29.37m

Company Profile

EyeGate Pharma is a clinical stage specialty pharmaceutical company, which engages in the development and commercialization of products for treating diseases and disorders of the eye. Its pipeline includes EGP-437 and Ocular Bandage Gel (OBG). OBG is a topically-applied eye drop formulation that is being developed under the 510k De Novo path for devices submitted for marketing clearance to the U.S. FDA. The company was founded in 1998 and is headquartered in Waltham, MA.